These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39350732)

  • 21. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
    Schmid CL; Raehal KM; Bohn LM
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming Depression with 5-HT
    Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of an Active Site Mutant Receptor for the Identification of Potent and Selective Atypical 5-HT
    Carpenter J; Wang Y; Wu G; Feng J; Ye XY; Morales CL; Broekema M; Rossi KA; Miller KJ; Murphy BJ; Wu G; Malmstrom SE; Azzara AV; Sher PM; Fevig JM; Alt A; Bertekap RL; Cullen MJ; Harper TM; Foster K; Luk E; Xiang Q; Grubb MF; Robl JA; Wacker DA
    J Med Chem; 2017 Jul; 60(14):6166-6190. PubMed ID: 28635286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT
    Varty GB; Canal CE; Mueller TA; Hartsel JA; Tyagi R; Avery K; Morgan ME; Reichelt AC; Pathare P; Stang E; Palfreyman MG; Nivorozhkin A
    J Med Chem; 2024 Apr; 67(8):6144-6188. PubMed ID: 38593423
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Petersen IN; Villadsen J; Hansen HD; Madsen J; Jensen AA; Gillings N; Lehel S; Herth MM; Knudsen GM; Kristensen JL
    Org Biomol Chem; 2017 May; 15(20):4351-4358. PubMed ID: 28474719
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of a hallucinogenic serotonin 5-HT
    Zhang G; Cinalli D; Stackman RW
    Hippocampus; 2017 May; 27(5):558-569. PubMed ID: 28176400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
    Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
    Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Selective" serotonin 5-HT
    Casey AB; Cui M; Booth RG; Canal CE
    Biochem Pharmacol; 2022 Jun; 200():115028. PubMed ID: 35381208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of 5-HT
    Gao J; Wu R; Davis C; Li M
    Neuropharmacology; 2018 Jan; 128():96-105. PubMed ID: 28965828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
    Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
    J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT
    Leth-Petersen S; Petersen IN; Jensen AA; Bundgaard C; Bæk M; Kehler J; Kristensen JL
    ACS Chem Neurosci; 2016 Nov; 7(11):1614-1619. PubMed ID: 27564969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Discovery of Functionally Selective Serotonin 2C (5-HT
    Cheng J; McCorvy JD; Giguere PM; Zhu H; Kenakin T; Roth BL; Kozikowski AP
    J Med Chem; 2016 Nov; 59(21):9866-9880. PubMed ID: 27726356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, Synthesis, Molecular Docking, and Biological Evaluation of Novel Pimavanserin-Based Analogues as Potential Serotonin 5-HT
    Albujuq NR; Meana JJ; Diez-Alarcia R; Muneta-Arrate I; Naqvi A; Althumayri K; Alsehli M
    J Med Chem; 2023 Jul; 66(13):9057-9075. PubMed ID: 37378639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT
    Gao J; Chen L; Li M
    Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice.
    Odland AU; Kristensen JL; Andreasen JT
    Behav Pharmacol; 2021 Aug; 32(5):448-452. PubMed ID: 33595957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of bidentate ligands designed to interact with PDZ domains.
    Boucherle B; Vogrig A; Deokar H; Bouzidi N; Ripoche I; Thomas I; Marin P; Ducki S
    Bioorg Med Chem; 2011 Jul; 19(14):4346-54. PubMed ID: 21680189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
    Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
    ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.